Product Program year 2025 Source: CMS Open Payments

Spectralis

Device Ophthalmology Imaging Equipment

Open in the dashboard

General payments

$3,218,024

651 payments

Research payments

$0

0 payments

Through program year 2025, $3,218,024 in general payments and $0 in research payments were reported against Spectralis (Ophthalmology Imaging Equipment).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $80,653 93
2024 General $361,455 68
2023 General $832,685 110
2022 General $665,365 88
2021 General $338,509 102
2020 General $679,303 67
2019 General $260,053 123

Breakdown

Who paid General payments · program years 2019–2025
  1. Heidelberg Engineering, Inc. $3,218,024 651 payments
Top recipients General payments · program year 2025
  1. Shaheen Kavoussi Ophthalmology · Houston, TX $16,800 21% · 1 payment
  2. Legacy Emanuel Hospital & Health Ctr Teaching hospital · OR $14,310 18% · 1 payment
  3. University Of Miami Hospital Teaching hospital · FL $5,000 6% · 1 payment
  4. Jack Holladay Bellaire, TX $4,800 6% · 1 payment
  5. James Fanelli Optometrist · Wilmington, NC $4,359 5% · 3 payments

The top 5 of 78 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $23,233 49% · 42 practitioners
  2. Optometrist $16,828 35% · 17 practitioners
  3. Retina Specialist Ophthalmology $7,139 15% · 10 practitioners
  4. Cornea and External Diseases Specialist Ophthalmology $156 <1% · 1 practitioner
  5. Glaucoma Specialist Ophthalmology $130 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Texas $32,650 40% · 15 recipients
  2. Oregon $15,341 19% · 12 recipients
  3. California $7,263 9% · 7 recipients
  4. North Carolina $6,917 9% · 2 recipients
  5. Florida $5,433 7% · 6 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

651 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record